Estelle ZUSELLI

En résumé

Entreprises

• Laboratoire JANSSEN - Sales Manager

  2012 - maintenant Sales Management Paris (Pariet® / Effentora® / Durogesic® / Biafine® / Immunology Partnership)
  13 sales reps management
  
  Major Achievements:
  
  • 1st in growth (Paris : +22% - IDF : +13%)
  • Exceed sales objectives (Paris : +9% - IDF : +7%)

• Laboratoire JANSSEN - Oncology Marketing Manager & Country Value Team Leader France

  2007 - 2011 Eprex & Caelyx Marketing Manager (EPREX Oncology / Hematology / Surgery / nephrology Business) : 90M€ – CAELYX : 30M€
  Team: 2 Marketers + 1 trainee + 1 assistant
  
  Major Achievements:
  • Talent people development
  • Coordinate Janssen Marketing Teams to implement Marketing campaign on Ipad
  • Drive CAELYX transfer from Schering Plough/ Merck to Janssen (January 2011)
  • Develop a global Oncology strategy through patient approach Caelyx (1st Chemotherapy : curative treatment) & Oncology Supportive Care portfolio (Eprex / Durogesic / Effentora)
  • Successfully lead the French Eprex Core Value Team to support the IBVT (European Organization) on new indication development project (Myelodysplastic syndrome MA)
  • Develop Innovative multichannel strategy in Hematology (CONNECT project oriented)
  • Convince JCF Board to invest in Surgery business (FTEs investment)
  • Exceed Eprex Oncology sales objectives in a highly competitive market (3 biosimilars)
  thanks to Eprex Protecs Launch and better brand plan implementation : 2nd ESA of the market.
  • Bring Eprex as the most competitive ESA in Nephrology after sub-cutaneous relaunch: Growth YTD08: +12% - YTD09: +6%

• JOHNSON & JOHNSON Wound Management - ETHICON - Marketing Director

  2003 - 2007 Responsible for developing innovative commercialization strategies
  Responsible of Late Life Cycle Management and new product segment development: Integra Regranex relaunch (Janssen-Cilag product) - 30M€
  Team: 5 Marketers + Communication department
  
  Major Achievements:
  • Launch a new distribution channel: Direct Sales to Pharmacists (1.3M€ in 1st Year)
  • Boost Internal and external Collaboration to maximize Business:
  Biafine® (J&J Consumer France) / Algosteril (Brothier) / Effidia (Medix)
  • Influence role in Leadership Meeting
  • Involve in Market Access for Reimbursement re-evaluation (Lobbying HAS / CEPP)

• JOHNSON & JOHNSON Wound Management - Advanced Wound Care Product Manager Senior

  New Brunswick 2000 - 2003 Responsible for 80% of Wound Management Business
  
  Major Achievements:
  • Constantly achieve best EMEA results, overtaking US
  • Gain significant market shares and reach leadership position on the Moist Wound Healing Market
  • Appointed as European Brand Team Meeting Member

• Johnson & Johnson Wound Management - Anti-infective Product Manager France & European Antimicrobial Product Manager

  New Brunswick 1999 - 2000 Responsible for antimicrobial product strategy
  
  Major Achievements:
  • Position Actisorb as the 1st antimicrobial on AWC Market
  • Win Bellringer Award recognition for the Best J&J Promotional Campaign
  • Pioneer the 1st Worldwide Antimicrobial Product Manager Education Event

• Johnson & Johnson Medical - Advanced Wound Care Product Manager

  New Brunswick 1997 - 1999 Major Achievements:
  • Launch of the 1st Advanced Wound care range in France thence revolutionize the Healing Market profile and change treatment paradigm
  • Played an instrumental role in the Franchise creation (80 reps)

Formations

• University Pierre & Marie Curie – Paris 6

  Paris 1996 - 1997 Master Pharmaceutical Marketing

• University Pierre & Marie Curie – Paris 6

  Paris 1992 - 1996 Master Biochemistry

Réseau

• Farida CARDOSO

• Franck POUPPEVILLE

• Francoise SHNEIKER

• Lotfi BENZEMAM

• Marc-Olivier BÉVIERRE

• Michael GILLE

• Olivier FOX

• Stéphane EIFLER